Recombinant Human Erythropoietin Treatment in Pre-Dialysis Patients

2020 
Abstract Study Objective:To determine the efficacy and safety of recombinant human erythropoietin (r-HuEPO) in predialysis renal patients. Design:Randomized, double-blind, placebo-controlled trial ...
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    1
    Citations
    NaN
    KQI
    []